MedPath

Investigation of Heart Failure Status Over Time Using Respiratory Parameters

Completed
Conditions
Heart Failure, Congestive
Sleep Apnea Syndromes
Registration Number
NCT00494117
Lead Sponsor
ResMed
Brief Summary

The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)
Exclusion Criteria
  • Malignant disease affecting gas exchange or respiratory parameters
  • Medications compromising breathing with no adverse affects on heart failure
  • Clinically significant (moderate to severe) asthma requiring therapy
  • Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)
  • Severe pulmonary hypertension
  • Heart failure due to alcohol abuse or chemotherapy
  • Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)
  • Alcohol consumption > 80g/day
  • Patients receiving home Oxygen
  • Methicillin- resistant Staphylococcus aureus infection
  • Narcolepsy
  • Cataplexy
  • Enrolled in any concurrent study, that may confound the results of this study.
  • Inability or refusal to sign the Patient Consent Form
  • Inability or refusal to adhere to protocol requirements

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Royal Prince Alfred Hospital

🇦🇺

Camperdown, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath